MICROTEST INC
S-8, 1998-12-04
INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS
Previous: MNB BANCSHARES INC, S-8, 1998-12-04
Next: MICROTEST INC, S-8, 1998-12-04



     AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON DECEMBER 4,1998
                                                 REGISTRATION NO. ______________
================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                   ----------

                                    FORM S-8
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933

                                   ----------

                                 MICROTEST, INC.
               (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)

         DELAWARE                                                 86-0485884
(STATE OR OTHER JURISDICTION                                  (I.R.S. EMPLOYER
OF INCORPORATION OR ORGANIZATION)                            IDENTIFICATION NO.)


                 4747 NORTH 22ND STREET, PHOENIX, ARIZONA 85016
               (ADDRESS OF PRINCIPAL EXECUTIVE OFFICE) (ZIP CODE)


                  NON-QUALIFIED STOCK OPTION AGREEMENTS BETWEEN
                     MICROTEST, INC. AND CHARLES V. MIHAYLO
                              (FULL TITLE OF PLAN)


                             STEVEN D. PIDGEON, ESQ.
                              SNELL & WILMER L.L.P.
                               ONE ARIZONA CENTER
                           PHOENIX, ARIZONA 85004-0001
                     (NAME AND ADDRESS OF AGENT FOR SERVICE)

                                 (602) 382-6000
          (TELEPHONE NUMBER, INCLUDING AREA CODE, OF AGENT FOR SERVICE)


Approximate Date of Commencement of Proposed Sale: As soon as practicable  after
the Registration Statement becomes effective.

================================================================================
<PAGE>

                         CALCULATION OF REGISTRATION FEE
================================================================================
                                    PROPOSED         PROPOSED
   TITLE OF         AMOUNT          MAXIMUM          MAXIMUM          AMOUNT OF
  SECURITIES        TO BE        OFFERING PRICE     AGGREGATE       REGISTRATION
TO BE REGISTERED  REGISTERED(1)   PER SHARE(2)   OFFERING PRICE(2)       FEE
- ----------------  -------------  --------------  -----------------  ------------

Common Stock        60,000          $3.8125          $228,750          $63.59
$.001 par value
================================================================================

- ----------

(1)      In addition,  pursuant to Rule 416(a) under the Securities Act of 1933,
         this  registration  statement  also covers an  indeterminate  number of
         shares  as  may  be   required   by  reason  of  any  stock   dividend,
         recapitalization,  stock split, reorganization,  merger, consolidation,
         combination or exchange of shares or other similar change affecting the
         stock.

(2)      Estimated pursuant to Rule 457(h) solely for the purpose of calculating
         the  registration  fee  using  the price at which  each  option  may be
         exercised  pursuant  to  the  provisions  of the  employment  agreement
         between Microtest, Inc. and Charles V. Mihaylo.

                                        2
<PAGE>
                                     PART I
              INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

         The documents  containing the information  specified in Part I, Items 1
and 2, will be delivered to  participants  in accordance  with Form S-8 and Rule
428 under the Securities Act of 1933, as amended.

                                     PART II
               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.

         The  following  documents  have  been  filed by  Microtest,  Inc.  (the
"Registrant")  with the  Securities  and  Exchange  Commission  pursuant  to the
Securities  Exchange Act of 1934 and are hereby  incorporated  by reference into
this Registration Statement:

            (a)   the  Registrant's  latest  annual  report on Form 10-K for the
                  fiscal year ended December 31, 1997;

            (b)   the Registrant's quarterly reports on Form 10-Q for the fiscal
                  quarters  ended March 28, 1998,  June 27, 1998,  and September
                  26, 1998; and

            (c)   the description of the Registrant's capital stock contained in
                  the Registrant's Registration Statement on Form 8-A filed with
                  the  Securities  and Exchange  Commission  pursuant to Section
                  12(g) of the Securities Exchange Act of 1934.

         All documents subsequently filed by the Registrant pursuant to Sections
13(a),  13(c), 14, or 15(d) of the Securities Exchange Act of 1934, prior to the
filing of a post-effective amendment which indicates that all securities offered
have been sold or which deregisters all securities then remaining unsold,  shall
be deemed to be incorporated by reference in this Registration  Statement and to
be a part hereof from the date of filing such documents. Any statement contained
in a document  incorporated  or deemed to be  incorporated  by reference  herein
shall be deemed to be modified or superseded  for purposes of this  Registration
Statement to the extent that a statement contained herein or in any subsequently
filed document which also is or is deemed to be incorporated by reference herein
modifies or supersedes such  statement.  Any statement so modified or superseded
shall not be deemed,  except as so modified or superseded,  to constitute a part
of this Registration Statement.

ITEM 4. DESCRIPTION OF SECURITIES.

         Not applicable.

ITEM 5. INTERESTS OF NAMED EXPERTS AND COUNSEL.

         Not applicable.

                                        3
<PAGE>
ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.

         The  Registrant's  Bylaws  require  the  Registrant  to  indemnify  its
directors  and  officers to the fullest  extent  provided by Delaware  law.  The
Registrant  also has entered into separate  indemnification  agreements with its
directors and certain  officers which would require the Registrant,  among other
things,  to indemnify them against certain  liabilities that may arise by reason
of their  status or service as directors  or  officers,  other than  liabilities
arising  from fraud,  actual  dishonesty,  willful  misconduct  or  violation of
Section 16(b) of the Securities  Exchange Act of 1934. The agreements would also
require the  Registrant to advance  directors and officers'  expenses in certain
circumstances.

         The Registrant  currently maintains  directors' and officers' liability
insurance.

ITEM 7. EXEMPTION FROM REGISTRATION CLAIMED.

         Not applicable.

ITEM 8. EXHIBITS.

         The Exhibit Index is located on page 7.

ITEM 9. UNDERTAKINGS.

            (a)   The undersigned Registrant hereby undertakes:

                  (1)   To file,  during any period in which offers or sales are
                        being  made,   a   post-effective   amendment   to  this
                        registration statement:

                        (i)   To  include  any  prospectus  required  by section
                              10(a)(3) of the Securities Act of 1933;

                        (ii)  To reflect in the  prospectus  any facts or events
                              arising   after   the   effective   date   of  the
                              registration  statement  (or the most recent post-
                              effective  amendment thereof) which,  individually
                              or  in  the  aggregate,  represent  a  fundamental
                              change  in  the   information  set  forth  in  the
                              registration   statement.    Notwithstanding   the
                              foregoing,  any  increase or decrease in volume of
                              securities  offered (if the total  dollar value of
                              securities offered would not exceed that which was
                              registered) and any deviation from the low or high
                              end of the estimated maximum offering range may be
                              reflected in the form of prospectus filed with the
                              Commission  pursuant  to Rule  424(b)  if,  in the
                              aggregate,   the   changes  in  volume  and  price
                              represent  no more than 20% change in the  maximum
                              aggregate   offering   price   set  forth  in  the
                              "Calculation  of  Registration  Fee"  table in the
                              effective registration statement;

                        (iii) To include any material  information  with respect
                              to  the  plan  of   distribution   not  previously
                              disclosed  in the  registration  statement  or any
                              material   change  to  such   information  in  the
                              registration statement;

                                        4
<PAGE>
                               provided, however, that paragraphs (a)(1)(i) and
                               (a)(1)(ii)  do not  apply  if  the  registration
                               statement  is on Form  S-3 or  Form  S-8 and the
                               information   required   to  be  included  in  a
                               post-effective  amendment by those paragraphs is
                               contained  in  periodic  reports  filed  by  the
                               Registrant  pursuant  to  Section  13 or Section
                               15(d)  of the  Securities  Exchange  Act of 1934
                               that  are   incorporated  by  reference  in  the
                               registration statement.

                  (2)   That,  for purposes of determining  any liability  under
                        the  Securities  Act of 1933,  each such  post-effective
                        amendment  shall  be  deemed  to be a  new  registration
                        statement  relating to the securities  offered  therein,
                        and the offering of such  securities  at that time shall
                        be deemed to be the initial bona fide offering thereof.

                  (3)   To remove from registration by means of a post-effective
                        amendment any of the securities  being  registered which
                        remain unsold at the termination of the offering.

      (b)   The undersigned  Registrant  hereby undertakes that, for purposes of
            determining  any liability  under the Securities  Act of 1933,  each
            filing of the  Registrant's  annual report pursuant to section 13(a)
            or section 15(d) of the Securities  Exchange Act of 1934 (and, where
            applicable,  each filing of an employee benefit plan's annual report
            pursuant to section  15(d) of the  Securities  Exchange Act of 1934)
            that is  incorporated  by  reference in the  registration  statement
            shall be deemed to be a new registration  statement  relating to the
            securities  offered therein,  and the offering of such securities at
            that  time  shall be  deemed to be the  initial  bona fide  offering
            thereof.

      (c)   Insofar  as  indemnification   for  liabilities  arising  under  the
            Securities  Act of 1933 may be permitted to directors,  officers and
            controlling  persons of the  Registrant  pursuant  to the  foregoing
            provisions,  or otherwise,  the  Registrant has been advised that in
            the  opinion  of  the  Securities  and  Exchange   Commission   such
            indemnification  is against  public  policy as expressed in such Act
            and is,  therefore,  unenforceable.  In the  event  that a claim for
            indemnification  against such liabilities (other than payment by the
            Registrant  of expenses  incurred or paid by a director,  officer or
            controlling  person of the Registrant in the  successful  defense of
            any  action,  suit or  proceeding)  is  asserted  by such  director,
            officer or  controlling  person in  connection  with the  securities
            being registered,  the Registrant will, unless in the opinion of its
            counsel the matter has been settled by controlling precedent, submit
            to a court of  appropriate  jurisdiction  the question  whether such
            indemnification  by it is against  public policy as expressed in the
            Act and will be governed by the final adjudication of such issue.

                                        5
<PAGE>
                                   SIGNATURES

         Pursuant  to the  requirements  of the  Securities  Act  of  1933,  the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration
Statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized, in the City of Phoenix, State of Arizona, on December 4, 1998.

                                          MICROTEST, INC.
                                          a Delaware corporation

                                          By /s/ Richard G. Meise
                                            -------------------------------
                                            Richard G. Meise
                                            Chairman of the Board and Chief
                                            Executive Officer

         Pursuant  to the  requirements  of the  Securities  Act of  1933,  this
Registration  Statement  has been signed below by the  following  persons in the
capacities and on the date indicated.

     Signature                      Title                    Date
     ---------                      -----                    ----

/s/ Richard G. Meise
- ----------------------    Chairman of the Board and        December 4, 1998
Richard G. Meise          Chief Executive Officer

/s/ Steven G. Mihaylo
- ----------------------    Director                         December 4, 1998
Steven G. Mihaylo

/s/ Roger C. Ferguson
- ----------------------    Director                         December 4, 1998
Roger C. Ferguson

/s/ William C. Turner
- ----------------------    Director                         December 4, 1998
William C. Turner

/s/ Dianne C. Walker
- ----------------------    Director                         December 4, 1998
Dianne C. Walker

/s/ Kent C. Mueller
- ----------------------    Director                         December 4, 1998
Kent C. Mueller

/s/ John J. O'Block
- ----------------------    Vice President of Operations,    December 4, 1998
John J. O'Block           Chief Financial Officer,
                          Treasurer and Secretary
                          (Principal Financial Officer
                          and Principal Accounting Officer)

                                        6
<PAGE>
                                  EXHIBIT INDEX


EXHIBIT                                                        PAGE OR METHOD
NUMBER                         DESCRIPTION                       OF FILING
- ------                         -----------                       ---------

 4.1      Employment Agreement between the Company and             Page  8
          Charles V. Mihaylo

 4.2      Non-Qualified Stock Option Agreement                     Page 19

 4.3      Non-Qualified Stock Option Agreement                     Page 25

 5        Opinion regarding Legality                               Page 31

23.1      Consent of Independent Accountants                       Page 33

23.2      Consent of Snell & Wilmer L.L.P.                         See Exhibit 5


                                        7


                                   EXHIBIT 4.1

                              EMPLOYMENT AGREEMENT

         This EMPLOYMENT AGREEMENT (the "Agreement") is made as of June 9, 1997,
by and  among  MICROTEST,  INC.,  a  Delaware  corporation  ("Microtest"  or the
"Company"), and CHARLES V. MIHAYLO, an individual ("Mihaylo").

                                    RECITALS

         A.  Microtest  desires  to  employ  Mihaylo  as  its  President,  Chief
Operating Officer and Acting Chief Financial Officer effective immediately;

         B.  Mihaylo  desires  to be  employed  by  Microtest  to  serve in such
capacities; and

         C.  Microtest  and  Mihaylo  anticipate  that  Microtest  will  hire  a
full-time Chief Financial Officer at a time deemed appropriate by Microtest, and
that Mihaylo will be relieved of those  additional  duties without  reduction in
compensation provided in this Agreement;

         NOW, THEREFORE,  in consideration of the mutual covenants,  agreements,
representations and warranties  contained herein and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties hereby covenant and agree as follows:

         1. Definitions. As used herein:

                  (a)   "Company    Confidential    Information"    shall   mean
         confidential,  proprietary  information  or trade  secrets of Microtest
         including  without  limitation  the  following:  (1) customer lists and
         customer  information  as compiled  by  Microtest,  including  customer
         orders, product usage, product volumes,  pricing,  customer technology,
         sale and contract terms and conditions, contract expirations, and other
         compiled customer  information;  (2) Microtest's internal practices and
         procedures;  (3) Microtest's  financial condition and financial results
         of operation to the extent not generally  available to the public;  (4)
         supply of  materials  information,  including  sources  and costs;  (5)
         information   relating   to   designs,   formulas,   developmental   or
         experimental work, know-how,  products,  processes,  computer programs,
         source codes, data bases, designs, schematics,  inventions,  creations,
         original  works of  authorship,  or other  subject  matter  related  to
         Microtest's    research   and    development,    strategic    planning,
         manufacturing,  engineering, purchasing, finance, marketing, promotion,
         distribution,   and  selling  activities,   whether  now  existing,  or
         acquired,  developed,  or  made  available  anytime  in the  future  to
         Microtest;  (6) all information which Mihaylo has a reasonable basis to
         consider confidential or which is treated by Microtest as confidential;
         and (7) any and all information  having  independent  economic value to
         Microtest that is not generally known to, and not readily ascertainable
         by proper  means by,  persons  who can obtain  economic  value from its
         disclosure  or use.  Mihaylo  acknowledges  that  such  information  is
         Company  Confidential  Information  whether  disclosed to or learned by
         Mihaylo or originated by Mihaylo during employment by Microtest. In the
         event that information is not clearly and obviously publicly available,
         all information about Microtest shall be presumed to be confidential.

                                       1
<PAGE>
                  (b)  "Microtest"  shall mean Microtest and any other entity in
         which  it  owns  directly  or  indirectly  50% or  more  of the  equity
         interest,  including without limitation Logicraft  Information Systems,
         Inc. and Optical Media International.

                  (c) "Microtest  Stock" shall mean the Common Stock,  $.001 par
         value per share, of Microtest, Inc.

         2. Term of  Agreement.  This  Agreement  shall  commence as of the date
hereof and shall  continue  for a term of five (5)  years,  subject to the other
provisions  hereof (the "Term").  The parties may extend the Term for additional
one-year terms by mutual written  agreement.  Except in the event of termination
for Cause, any party intending not to extend the Term or any one-year  extension
thereof, shall provide written notice to the other party of its or his intention
not to extend at least ninety (90) days prior to the  expiration  of the Term or
any one-year extension thereof; provided, however, that the failure to give such
ninety-day notice shall not operate to extend the Term or any one-year extension
thereof for any period of time.

         3. Positions with  Microtest.  During the Term,  Mihaylo shall serve as
the President,  Chief Operating  Officer and Acting Chief  Financial  Officer of
Microtest.  Mihaylo shall devote his full time,  energy and skill to the affairs
of Microtest and shall faithfully and diligently perform all duties commensurate
with such positions,  including,  without limitation,  those duties requested by
Microtest's  Board of Directors or the  Chairman  and Chief  Executive  Officer.
Mihaylo  shall be subject to and comply  with all of  Microtest's  policies  and
procedures.

         4. Salary.  Mihaylo  shall be entitled to receive a minimum base salary
in the amount of $200,000 annually,  payable in equal installments in accordance
with  Microtest's  general  salary  payment  policies in effect  during the term
hereof (the "Minimum Base  Salary").  Mihaylo's  Minimum Base Salary may, at the
sole  discretion of Microtest's  Board of Directors,  be increased at such times
and in such amounts as the Board shall determine.

         5.  Signing  Bonus.  Within  five  (5)  days  after  the  date  of this
Agreement,  Microtest  shall pay  Mihaylo a bonus in the amount of $75,000  (the
"Signing  Bonus").  If within one (1) year of the date of this Agreement  either
Microtest  terminates  Mihaylo's  employment  for  Cause (as  defined  below) or
Mihaylo  voluntarily  terminates  his  employment,  then Mihaylo shall repay the
Signing Bonus in full.

         6. Bonus.  Mihaylo  shall be entitled to  participate  in an  executive
bonus program.  Such bonus program shall be agreed upon by Microtest's  Chairman
and Chief Executive  Officer prior to June 30, 1997, but shall be subject to the
approval of the  Compensation  Committee of the Board of  Directors.  Such bonus
program shall be attached as Exhibit A to this Agreement.

         7. Options.  Microtest  shall grant Mihaylo (i) a  non-qualified  stock
option to acquire  175,000  shares of  Microtest  Stock in  accordance  with the
Company's  standard   non-qualified  stock  option  agreement  (the  "Employment
Option");  and (ii) an additional  non-qualified stock option to acquire 150,000
shares  of  Microtest  Stock  that  will  vest at the end of six years but which
vesting  will be  accelerated  at the rate of  25,000  shares  per year upon the
satisfaction of performance criteria

                                        2
<PAGE>
established  by Microtest (the  "Performance  Option").  Microtest  shall file a
registration  statement  on Form S-8 with  respect to the  issuance of Microtest
Stock upon the exercise by Mihaylo of the Employment  Option and the Performance
Option.  Neither  the  Employment  Option nor the  Performance  Option  shall be
granted pursuant to Microtest's Long-Term Incentive Plan.

         8. Benefit Plans. Mihaylo shall be afforded benefits (i.e., sick leave,
medical  and other  group  benefits)  similar  to those  afforded  to  executive
officers  of  Microtest.  So  long  as  Mihaylo  elects  not to  participate  in
Microtest's  medical  plan,  Microtest  shall  pay to  Mihaylo  each  month  the
prevailing  amount that otherwise would have been paid by Microtest on behalf of
Mihaylo for coverage under Microtest's  medical plan.  Mihaylo shall be entitled
to four (4) weeks of paid  vacation per year.  Nothing in this  Agreement  shall
restrict  Microtest's  ability  to  terminate  or  modify  any  benefit  plan or
arrangement;  provided,  however,  that  Microtest  shall  not  be  entitled  to
terminate  or  modify  the  medical  plan  payments  and  vacation  arrangements
specifically  provided  to Mihaylo  in this  Section 8 without  Mihaylo's  prior
written  consent.  Any such  termination or  modification of any benefit plan or
vacation arrangements shall not serve to forfeit any accrued but unused benefits
earned by Mihaylo.

         9.  Expenses.  Microtest  shall pay for or  reimburse  Mihaylo  for all
ordinary  and  necessary  business  expenses  incurred  or  paid by  Mihaylo  in
furtherance  of  Microtest's  business,   subject  to  and  in  accordance  with
Microtest's  policies and  procedures of general  application.  Microtest  shall
provide Mihaylo with a monthly automobile allowance of $500.

         10.  Non-Competition.  Mihaylo  covenants  and agrees that he will not,
during the term hereof and for one (1) year after any termination of employment,
within any jurisdiction in which Microtest does business:

                  (a)  Directly  or  indirectly  participate  or  assist  in the
         ownership,  management, operation or control of any business similar to
         or competitive with Microtest; provided, however, that Mihaylo may own,
         directly or  indirectly,  solely as an  investment,  securities  of any
         person which are traded on any national  securities  exchange or in the
         over the counter market if Mihaylo (x) is not a controlling  person of,
         or a member of a group  which  controls,  such  person or (y) does not,
         directly or  indirectly,  own 1% or more of any class of  securities of
         such person; or

                  (b) Directly or indirectly  solicit for  employment any person
         who is,  or  within  the six month  period  preceding  the date of such
         solicitation was, an employee of Microtest; or

                  (c) Call on or  directly  or  indirectly  solicit or divert or
         take away from Microtest any person, firm, corporation, or other entity
         who is a customer or supplier of Microtest.

         11.  Confidentiality  and  Nondisclosure.  It is understood that in the
course of Mihaylo's  employment with Microtest,  Mihaylo will become  acquainted
with  Company   Confidential   Information.   Mihaylo  recognizes  that  Company
Confidential Information has been developed or

                                        3
<PAGE>
acquired at great expense, is proprietary to Microtest,  and is and shall remain
the exclusive  property of Microtest.  Accordingly,  Mihaylo agrees that he will
not,  without  the  express  written  consent  of  Microtest,  during  Mihaylo's
employment  with  Microtest  and  thereafter  or  until  such  time  as  Company
Confidential  Information  becomes generally known, or readily  ascertainable by
proper means, by persons unrelated to Microtest,  disclose to others, copy, make
any use of,  or  remove  from  Microtest's  premises  any  Company  Confidential
Information, except as Mihaylo's duties for Microtest may specifically require.

         12. Reasonableness of Scope; Remedies.  Mihaylo acknowledges and agrees
that a  breach  by  Mihaylo  of the  provisions  of  Sections  10 and 11 of this
Agreement  will cause  Microtest  irreparable  injury and damage  that cannot be
reasonably  or  adequately  compensated  by  damages  at  law.  Mihaylo  further
acknowledges  and  agrees  that  he has  such  skills  and  abilities  that  the
provisions  of this  Sections  10 and 11 will not  prevent  him from  earning  a
living.  Mihaylo expressly agrees that Microtest shall be entitled to injunctive
or other equitable  relief to prevent a threatened  breach,  breach or continued
breach of Sections 10 or 11 hereof in  addition  to any other  remedies  legally
available to it.

         13.  Extension  During  Breach.  Mihaylo  agrees that the time  periods
described  in  Sections 10 and 11 shall be  extended  for a period  equal to the
duration of any breach of this Agreement by Mihaylo.

         14.  Disclosure.  Mihaylo agrees that upon the  commencement  by him of
employment with any third party during the period in which the terms of Sections
10 or 11 hereof are in effect,  Mihaylo shall promptly disclose to each such new
employer the terms of Sections 10 and 11. Mihaylo  further agrees and authorizes
Microtest to notify  others,  including  customers of the Microtest and any such
future  employers of Mihaylo,  of the terms of this  Agreement  and of Mihaylo's
obligations hereunder.

         15. No Conflicts of Interest.

                  (a) During the period of Mihaylo's  employment with Microtest,
         Mihaylo will not independently  engage in the same or a similar line of
         business as Microtest, or, directly or indirectly, serve, advise, or be
         employed by any individual, firm, or corporation engaged in the same or
         similar line of business.

                  (b) Mihaylo is not a promoter,  director, employee, or officer
         of, or consultant to, a business for profit,  nor will Mihaylo become a
         promoter,  director,  employee, or officer of, or consultant to, such a
         business while employed by Microtest  without first obtaining the prior
         written approval of Microtest, which approval shall not be unreasonably
         withheld.  Mihaylo disclaims any such relationship or position with any
         such business. Should Mihaylo become a promoter, director, employee, or
         officer of, or a consultant  to, a business  organized  for profit upon
         obtaining such prior written approval, Mihaylo understands that Mihaylo
         has a  continuing  obligation  to advise  Microtest at such time of any
         activity of Microtest

                                        3
<PAGE>
         or such  other  business  that  presents  Mihaylo  with a  conflict  of
         interest as an employee of Microtest.

                  (c) Should any matter of dealing in which Mihaylo is involved,
         or hereafter becomes  involved,  on his own behalf or as an employee of
         Microtest,  appear to present a possible conflict of interest under any
         Microtest  policy then in effect,  Mihaylo will  promptly  disclose the
         facts to  Microtest's  Chairman and Chief  Executive  Officer so that a
         determination  can be made as to whether a conflict  of  interest  does
         exist.  Mihaylo  will take  whatever  action is requested of Mihaylo by
         Microtest to resolve any conflict which it finds to exist.

         16. Return of Microtest Materials and Company Confidential Information.
Upon Termination,  Mihaylo shall promptly deliver to Microtest the originals and
all  copies  of any and all  materials,  documents,  notes,  manuals,  or  lists
containing or embodying Company Confidential  Information,  or relating directly
or  indirectly  to the business of  Microtest,  in the  possession or control of
Mihaylo.

         17. No Agreement With Others. Mihaylo represents,  warrants, and agrees
that Mihaylo is not a party to any  agreement  with any other person or business
entity, including former employers, that in any way affects Mihaylo's employment
by  Microtest  or  relates  to the same  subject  matter  of this  Agreement  or
conflicts with his  obligations  under this  Agreement,  or restricts  Mihaylo's
services to  Microtest.  Mihaylo may devote an amount of his time and efforts as
is mutually agreed upon by Microtest's  Chairman and Chief Executive Officer and
Mihaylo to assist  Mihaylo's former employer,  Inter-Tel,  Incorporated,  with a
period of transition following Mihaylo's departure; provided, however, that such
transition  period  shall not extend  beyond  January 1, 1998  unless  Microtest
consents  to any  such  extension,  which  consent  shall  not  be  unreasonably
withheld.

         18. Termination for Cause.  Microtest shall have the right to terminate
Mihaylo  for  Cause  if the  Board  or  Chairman  and  Chief  Executive  Officer
determines that any of the following events have occurred:

                  (a)  Mihaylo  fails  to  satisfactorily   perform  his  duties
         hereunder, engages in gross misconduct or otherwise materially breaches
         this Agreement;

                  (b) Mihaylo refuses or fails to follow any lawful direction of
         Microtest's Board of Directors,  Chairman or Chief Executive Officer or
         violates any lawful rule or regulation  established  by Microtest  from
         time to time regarding the conduct of its business; or

                  (c)  Mihaylo is charged  with or  convicted  of  committing  a
         felony or crime  involving  moral  turpitude,  or  engages  in  conduct
         involving  fraud,  dishonesty,  embezzlement,  theft or conduct that is
         detrimental  to Microtest or that could  reasonably be expected to have
         an  adverse  impact  on  the  standing  or  reputation  of  Mihaylo  or
         Microtest.

                                       4
<PAGE>
Microtest shall provide written notice of its intent to terminate this Agreement
for Cause  hereunder,  stating  the  grounds or nature of the  reasons  for such
termination.  With  respect to a purported  violation of  subsection  (a) or (b)
above that is curable in such time period,  Microtest  shall  afford  Mihaylo an
opportunity  to cure or disprove the purported  violation for the ten-day period
following such notice; provided, however, that Mihaylo shall be entitled to such
ten-day period to cure or disprove any purported violations only one time during
the Term.  Upon a  termination  for Cause,  Mihaylo shall be entitled to receive
only such  compensation  and benefits as are due Mihaylo  through the  effective
date of such termination.

         19.  Termination  Upon  Voluntary  Resignation.  In the  event  Mihaylo
voluntarily resigns his employment with Microtest,  Mihaylo shall be entitled to
receive  only such  compensation  and  benefits as are due  Mihaylo  through the
effective date of such resignation.

         20.  Termination  Upon  Death of  Mihaylo.  If during  the term of this
Agreement  Mihaylo dies, then this Agreement shall terminate and Microtest shall
pay to the estate of Mihaylo only the compensation  and benefits  (including any
life insurance benefits provided to Mihaylo's estate under Microtest's  standard
policies as in effect) due Mihaylo through the date of his death.

         21. Termination Upon Disability of Mihaylo.  If during the term of this
Agreement Mihaylo is unable to perform the services required of Mihaylo pursuant
to this Agreement for a continuous  period of ninety (90) days due to disability
or incapacity by reason of any physical or mental illness,  then Microtest shall
have the right to terminate this Agreement at the end of such three-month period
by giving written  notice to Mihaylo.  Mihaylo shall be entitled to receive only
his normal compensation and benefits through the date of his termination.

         22. Termination by Microtest Other than for Cause, Death, Disability or
Voluntary Resignation. Microtest shall have the right to terminate Mihaylo other
than for Cause, death, disability or voluntary resignation upon thirty (30) days
prior  written  notice to Mihaylo.  In the event  Microtest  elects to terminate
Mihaylo for any reason  other than for Cause,  death,  disability  or  voluntary
resignation  of  Mihaylo,  Mihaylo  shall be entitled to receive (i) the Minimum
Base  Salary due Mihaylo for one year  following  the date of such  termination,
which  shall be payable at the same time and amounts as if he  continued  in the
employ of Microtest,  and (ii) any accrued bonus if the executive  bonus program
for Mihaylo at that time  provides for accrued  bonuses,  which shall be payable
upon the expiration of the 30-day period referenced above.

         23. Arbitration.  Any dispute between the parties,  whether arising out
of or in connection  with this  Agreement,  shall be determined by  arbitration,
which,  other than the  relief  provided  in  Section  12  hereof,  shall be the
exclusive  remedy of the parties.  Any such dispute shall be submitted to and be
resolved  in  accordance   with  the  rules  and  regulations  of  the  American
Arbitration Association.  The arbitration shall be held in Phoenix, Arizona. The
arbitrators  shall state in writing the reasons for the award.  The  arbitrators
shall award compensatory  damages to the prevailing party. The arbitrators shall
have no authority to award  consequential or punitive or statutory damages,  and
the  parties  hereby  waive any claim to those  damages  to the  fullest  extent
allowed by law.

                                       5
<PAGE>
         24. Severability;  Reformation. If any court or arbiter determines that
any of the restrictive  covenants in this Agreement,  or any part thereof, is or
are invalid or unenforceable,  the remainder of the restrictive  covenants shall
not  thereby be  affected  and shall be given  full  effect,  without  regard to
invalid  portions.  If any of the  provisions of this  Agreement  should ever be
deemed to exceed the temporal,  geographic or occupational limitations permitted
by applicable  laws,  those  provisions  shall be and are hereby reformed to the
maximum temporal,  geographic or occupational  limitations  permitted by law. If
the court or arbiter  refuses to reform this  Agreement as provided  above,  the
parties  hereto  agree to modify  the  provisions  held to be  unenforceable  to
preserve each party's anticipated benefits thereunder.

         25.  Attorneys'  Fees.  In the  event  of  any  action,  proceeding  or
arbitration  arising from or relating to this  Agreement  or the alleged  breach
hereof,  the  party  prevailing  therein  shall  recover  its or his  reasonable
attorneys' fees and costs.

         26. Notices.  Any notice,  election or  communication to be given under
this Agreement  shall be in writing and delivered in person,  by telecopier,  or
deposited,  certified or registered, in the United States mail, postage prepaid,
addressed as follows:

                  If to Microtest:        Microtest, Inc.
                                          4747 North 22nd Street
                                          Phoenix, Arizona 85016-4708
                                          FAX: (602) 952-6604
                                          Attn:  Richard G. Meise

                  with copy to:           Snell & Wilmer L.L.P.
                                          One Arizona Center
                                          Phoenix, Arizona 85004-0001
                                          FAX: (602) 382-6070
                                          Attn: Steven D. Pidgeon, Esq.

                  If to Mihaylo:          Charles V. Mihaylo
                                          3112 East Palo Verde
                                          Phoenix, Arizona 85016
                                          FAX: (602)

                  with copy to:           Folk & Associates, P.C.
                                          One Columbus Plaza, Suite 810
                                          3636 North Central Avenue
                                          Phoenix, Arizona 85012
                                          FAX: (602) 263-8274
                                          Attn: P. Douglas Folk, Esq.

                                        6
<PAGE>
or to such  other  address  as  Microtest  or  Mihaylo  may,  from time to time,
designate in writing by notice hereunder.  Notices delivered  hereunder shall be
deemed to have been duly given: when delivered by hand, if personally delivered;
three (3) business days after being deposited in the mail,  postage prepaid,  if
delivered by mail; and when receipt is acknowledged, if telecopied.

         27. Entire  Agreement.  This  Agreement and any other document which is
specifically  referred to in this  Agreement  constitute and embody the full and
complete  understanding  and agreement of the parties hereto with respect to the
subject matter hereof,  and supersedes all prior  understandings  or agreements,
whether oral or in writing.

         28. Binding  Nature.  This Agreement shall be binding upon and inure to
the benefit of Microtest and its  successors  and assigns,  and upon Mihaylo and
his heirs and legal representatives.

         29. Captions; Headings. The captions and paragraph headings included in
this  Agreement are for  convenience  of reference  only and do not constitute a
part of this Agreement.

         30. Counterparts.  This Agreement may be executed in counterparts, each
of which shall be deemed an original,  but all of which shall constitute one and
the same document.

         31. Withholding.  Mihaylo acknowledges and agrees that payments made to
Mihaylo by Microtest  pursuant to the terms of this  Agreement may be subject to
tax withholding and that Microtest may withhold against payments due Mihaylo any
such amounts as well as any other amounts payable by Mihaylo to Microtest.

         32.  Release.  Receipt of any of the benefits to be provided to Mihaylo
under this Agreement  following  termination of Mihaylo's  employment  hereunder
shall be subject to Mihaylo's compliance with any reasonable and lawful policies
or  procedures  of  Microtest  relating  to  employee  severance  including  the
execution  and  delivery  by Mihaylo  of a release  reasonably  satisfactory  to
Microtest of any and all claims that  Mihaylo may have against  Microtest or any
related person,  except for the continuing  obligations  provided herein, and an
agreement that Mihaylo shall not disparage Microtest.

         33.  Assignment by Microtest.  Nothing in this Agreement shall preclude
Microtest from  consolidating  or merging into or with, or  transferring  all or
substantially all of Microtest's  assets to, another  corporation or entity that
assumes  this  Agreement  and all  obligations  and  undertakings  of  Microtest
hereunder. Upon such consolidation, merger or transfer of assets and assumption,
the term "Microtest" as used herein shall mean such other corporation or entity,
and this Agreement shall continue in full force and effect.

         34.  Assignment by Mihaylo.  This  Agreement,  or any right or interest
hereunder,   may  not  be  assigned  by  Mihaylo,  his  beneficiaries  or  legal
representatives,  without Microtest's prior written consent; provided,  however,
that  nothing in this  Section 34 shall  preclude  Mihaylo  from  designating  a
beneficiary to receive,  or assigning to a trust or other entity  established by
Mihaylo for estate or financial  planning  purposes,  any benefit hereunder upon
Mihaylo's death, or shall preclude the

                                       7
<PAGE>
executors,  administrators  or other  legal  representatives  of  Mihaylo or his
estate from  assigning any right or interest  hereunder to the person or persons
entitled to such right or interest.

         35. Modification. No modification,  supplement,  amendment or waiver of
this  Agreement  shall be binding  unless  executed  in  writing by all  parties
hereto.  A waiver of any of the  provisions  of this  Agreement  shall be not be
deemed to or constitute a waiver of any other  provision  hereof,  nor shall any
such waiver constitute a continuing waiver unless otherwise expressly provided.

         36.  Governing  Law. This  Agreement has been executed and delivered in
the  State  of  Arizona,  and  its  validity,  interpretation,  performance  and
enforcement  shall be  governed  by the laws of that  state  without  regard  to
conflict of law principles.

         37.  Construction.  This Agreement shall be construed fairly as to both
parties and not in favor of or against  either party,  regardless of which party
prepared this Agreement.



                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]


                                        8
<PAGE>

         IN WITNESS WHEREOF,  the parties have executed this Agreement as of the
date first written above.


                                         MICROTEST, INC., a Delaware corporation



                                         By:
                                            ------------------------------------
                                         Its:
                                             -----------------------------------

                                         --------------------------------------
                                         CHARLES V. MIHAYLO




                                        9
<PAGE>
                                    EXHIBIT A
                                  BONUS PROGRAM


         Mihaylo  shall be  entitled to a bonus for 1997 and 1998 based upon the
achievement  of earnings  before income tax ("EBIT")  goals.  The EBIT goals for
1997 and 1998 shall be $___________ and $___________, respectively.

         If Microtest's EBIT for 1997 is equal to or greater than $____________,
Mihaylo  shall  earn a bonus  equal to ___% of  Microtest's  EBIT for  1997.  If
Microtest's  EBIT  for  1997 is equal to or  greater  than  $____________,  then
Mihaylo shall earn an  additional  bonus equal to ___% of  Microtest's  EBIT for
1997.

         If Microtest's EBIT for 1998 is equal to or greater than $____________,
Mihaylo  shall  earn a bonus  equal to ___% of  Microtest's  EBIT for  1998.  If
Microtest's  EBIT  for  1998 is equal to or  greater  than  $____________,  then
Mihaylo shall earn an  additional  bonus equal to ___% of  Microtest's  EBIT for
1998.

         In no event shall the bonus  payable to Mihaylo for either 1997 or 1998
hereunder exceed $_______________.

         Any bonus earned by Mihaylo shall be paid by Microtest  within ten (10)
days after the completion of Microtest's  audited financial  statements for 1997
and 1998, as applicable.

         A bonus program will be  established  by mutual  agreement of Microtest
and Mihaylo for years  after  1998.  The goals to be achieved  and bonuses to be
earned by Mihaylo  under such bonus  program shall be agreed to at the beginning
of each year by Mihaylo,  Microtest's  Chairman and Chief Executive  Officer and
Microtest's Compensation Committee.


                                        10

                                   EXHIBIT 4.2

                      NON-QUALIFIED STOCK OPTION AGREEMENT

         This Non-Qualified Stock Option Agreement is made as of this 9th day of
June, 1997 (which date is hereinafter referred to as the "Date of Grant") by and
among MICROTEST,  INC., a Delaware corporation  (hereinafter  referred to as the
"Company") and Charles V. Mihaylo  (hereinafter  referred to as "Employee").  If
Employee is presently or  subsequently  becomes  employed by a subsidiary of the
Company,  the term "Company" shall be deemed to refer collectively to Microtest,
Inc. and the subsidiary or subsidiaries which employ the Employee.

                                    RECITALS

         A. From time to time, the Company grants stock options to key employees
and  officers of the Company as an  incentive to  encourage  key  employees  and
officers to remain in its  employment  and to enhance the ability of the Company
to attract new employees  whose  services are considered  unusually  valuable by
providing an  opportunity  to have a proprietary  interest in the success of the
Company; and

         B. The Compensation  Committee (the "Committee") of the Company's Board
of  Directors  believes  that the  granting of the Option  herein  described  to
Employee is consistent with the stated purposes for the grant of a stock option;

         NOW, THEREFORE, in consideration of the mutual covenants and conditions
hereinafter set forth and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Company and Employee agree
as follows:

         1. Grant of Option. The Company hereby grants to Employee the right and
option  (hereinafter  referred to as the  "Option")  to purchase an aggregate of
175,000 shares (such number being subject to adjustment as provided in paragraph
number 12 hereof) of  Microtest  Common  Stock  (the  "Stock")  on the terms and
conditions  herein set forth.  This Option may be  exercised in whole or in part
and from time to time only to the extent the Option is vested and as hereinafter
provided.

         2. Vesting. The Option shall vest as follows:

                  (a)  One-fifth  of the shares  shall vest  twelve  (12) months
            after the Date of Grant;

                  (b) One-fifth of the shares shall vest twenty-four (24) months
            after the Date of Grant;

                  (c) One-fiftth of the shares shall vest thirty-six (36) months
            after the Date of Grant;

                                        1
<PAGE>
                  (d) One-fifth of the shares shall vest forty-eight (48) months
            after the Date of Grant;

                  (e) One-fifth of the shares shall vest forty-eight (60) months
            after the Date of Grant;

            Purchase Price.  The price at which  Employee  shall be  entitled to
                  purchase the Stock  covered by the Option shall be $3.8125 per
                  share (the Fair Market Value on the Date of Grant).

         4. Term of Option.  The Option  hereby  granted  shall be and remain in
force and effect for a period of ten (10) years from the Date of Grant,  through
and  including  the  normal  close of  business  of the  Company on June 9, 2007
(hereinafter  referred  to  as  the  "Expiration  Date"),   subject  to  earlier
termination as provided in paragraphs 8 and 9 hereof.

         5.  Exercise of Option.  The Option may be exercised by Employee at any
time and from time to time on or after  twelve (12) months and one day after the
Date of Grant,  and  through  the  Expiration  Date as to all or any part of the
shares of the Stock then vested by delivery to the Company of written  notice of
exercise  and payment of the  purchase  price as provided in  paragraphs 5 and 6
hereof.

         6. Method of Exercising Option.  Subject to the terms and conditions of
this Option  Agreement,  the Option may be exercised  by timely  delivery to the
Company of written notice,  which notice shall be effective on the date received
by the  Company  (the  "Effective  Date").  The notice  shall  state  Employee's
election  to exercise  the  Option,  the number of shares in respect of which an
election to exercise has been made, the method of payment elected (see paragraph
7 hereof),  the exact name or names in which the shares will be  registered  and
the Social  Security  number of  Employee.  Such  notice  shall be signed by the
Employee  and shall be  accompanied  by  payment of the  purchase  price of such
shares.  In the event the Option shall be exercised by a person or persons other
than  Employee  pursuant to  paragraph 9 hereof,  such notice shall be signed by
such other person or persons and shall be accompanied by proof acceptable to the
Company of the legal right of such person or persons to exercise the Option. All
shares  delivered by the Company upon exercise of the Option as provided  herein
shall be fully paid and nonassessable upon delivery.

         7. Method of Payment for Options. Payment for shares purchased upon the
exercise  of the  Option  shall be made by the  Employee  in cash or such  other
method  permitted  by  the  Committee  in its  sole  discretion,  including  (i)
tendering shares, (ii) surrendering a stock award valued at Fair Market Value on
the date of surrender,  (iii) authorizing a third party to sell the shares (or a
sufficient  portion  thereof)  acquired  upon  exercise  of a stock  option  and
assigning  the  delivery  to the  Company  of a  sufficient  amount  of the sale
proceeds to pay for all the shares acquired  through such exercise,  or (iv) any
combination of the above.  For purposes of this  Agreement,  "Fair Market Value"
means with respect to Stock or any other property, the fair market value of such
Stock or other property as determined by the Committee in its discretion,  under
one of the  following  methods:  (i) the  average of the  closing  bid and asked
prices for the Stock as reported on any  national  securities  exchange on which
the Stock is then listed  (which shall include the Nasdaq  National  Market) for
that date or, if

                                        2
<PAGE>
no prices are so reported for that date,  such prices on the next preceding date
for which  closing  bid and asked  prices  were  reported;  or (ii) the price as
determined by such methods or procedures as may be established from time to time
by the Committee.

8.  Termination  of  Employment.  In the event that Employee is terminated as an
employee of or consultant to the Company for any reason other than for Cause, as
defined  below,  then  Employee  may at any time  within  three (3) months  next
succeeding  the effective  date of such  termination  exercise the Option to the
extent  that  Employee  was  entitled  to  exercise  the  Option  at the date of
termination, provided that in no event shall the Option, or any part thereof, be
exercisable  after the Expiration  Date. If Employee's  employment is terminated
for Cause, the Option shall lapse at the time of such termination.  For purposes
of this  Agreement,  "Cause" means if the Committee,  in its reasonable and good
faith  discretion,  determines  that  Employee  (i)  has  developed  or  pursued
interests  substantially  adverse to the Company,  (ii) materially  breached any
employment,  engagement  or  confidentiality  agreement or  otherwise  failed to
satisfactorily  discharge  his or her  duties,  (iii)  has  not  devoted  all or
substantially  all of his or her  business  time,  effort and  attention  to the
affairs of the Company  (or such lesser  amount as has been agreed to in writing
by the Company), (iv) is convicted of a felony involving moral turpitude, or (v)
has engaged in activities or omissions that are detrimental to the well-being of
the Company.

         9. Death of  Employee.  In the event of the death of Employee  within a
period during which the Option,  or any part thereof,  could have been exercised
by Employee,  including three (3) months after the date of Employee's death (the
"Option  Period"),  the Option  shall lapse  unless it is  exercised  within the
Option  Period and in no event later than  fifteen (15) months after the date of
Employee's death by the Employee's legal representative or representatives or by
the person or persons entitled to do so under Employee's last will and testament
or if the Employee  fails to make a  testamentary  disposition of such Option or
shall die  intestate,  by the person or persons  entitled to receive such Option
under  the  applicable  laws of  descent  and  distribution.  An  Option  may be
exercised following the death of the Employee only if the Option was exercisable
by the  Employee  immediately  prior to his or her death.  In no event shall the
Option,  or any part thereof,  be  exercisable  after the  Expiration  Date. The
Committee  shall have the right to require  evidence  satisfactory  to it of the
rights of any  person or  persons  seeking to  exercise  the  Option  under this
paragraph 9 to exercise the Option.

         10.  Nontransferability.  The Option  granted by this Option  Agreement
shall be exercisable  only during the term of the Option provided in paragraph 4
hereof and,  except as provided in  paragraphs  8 and 9 above,  only by Employee
during his lifetime  and while an Employee of the Company.  No right or interest
of employee in the option may be pledged,  encumbered,  or hypothecated to or in
favor of any party  other  than the  Company,  or shall be  subject to any lien,
obligation, or liability of Employee to any other party other than the Company.

         11.  Delivery  of Shares.  No shares of Stock shall be  delivered  upon
exercise of the Option until (i) the purchase price shall have been paid in full
in the manner herein  provided;  (ii)  applicable  taxes required to be withheld
have been paid or withheld in full; (iii) approval of any governmental authority
required in connection  with the Option,  or the issuance of shares  thereunder,
has been  received  by the  Company;  and  (iv) if  required  by the  Committee,
Employee has delivered to the

                                        3
<PAGE>
Committee an Investment  Letter in form and content  satisfactory to the Company
as provided in paragraph 14 hereof.

         12.  Adjustments.  In the event a stock  dividend is declared  upon the
Stock,  the  shares of Stock  then  subject  to the  Option  shall be  increased
proportionately  without any change in the aggregate purchase price therefor. In
the event the Stock shall be changed into or exchanged for a different number or
class  of  shares  of  Stock  or  of  another   corporation,   whether   through
reorganization,  recapitalization,  stock split-up, combination of shares, there
shall be substituted for each such share of Stock then subject to the Option the
number and class of shares of Stock into which each  outstanding  share of Stock
shall be so exchanged,  all without any change in the aggregate  purchase  price
for the shares then subject to the Option.

         13.  Change  of  Control.  A  Change  of  Control  shall,  in the  sole
discretion of the Committee:

                  (a) cause  the  Option to  become  fully  exercisable  and all
         restrictions  to lapse and allow  Employee  the right to  exercise  the
         Option prior to the occurrence of the event  otherwise  terminating the
         Option  over such  period as the  Committee,  in its sole and  absolute
         discretion, shall determine; or

                  (b) cause the Option to terminate, provided that the surviving
         or resulting  corporation shall tender an option or options to purchase
         its shares or exercise such rights on terms and  conditions,  as to the
         number of shares and rights and  otherwise,  which shall  substantially
         preserve the rights and benefits of Employee under this Agreement.

For purposes of this  Agreement,  "Change in Control" means and includes each of
the following: (i) there shall be consummated any consolidation or merger of the
Company in which the  Company is not the  continuing  or  surviving  entity,  or
pursuant to which  Stock  would be  converted  into cash,  securities,  or other
property,  other  than a merger  of the  Company  in which  the  holders  of the
Company's  Stock  immediately  prior to the merger  have the same  proportionate
ownership of beneficial  interest of common stock or other voting  securities of
the  surviving  entity  immediately  after  the  merger;  (ii)  there  shall  be
consummated any sale, lease, exchange or other transfer (in one transaction or a
series of related transactions) of assets or earning power aggregating more than
40% of the assets or earning power of the Company and its subsidiaries (taken as
a whole);  (iii) the  shareholders  of the  Company  shall  approve  any plan or
proposal for liquidation or dissolution of the Company; (iv) any person (as such
term is used in Sections  13(d) and 14(d)(2) of the Exchange Act) other than any
employee  benefit  plan of the Company or any  subsidiary  of the Company or any
entity  holding  shares of capital  stock of the  Company for or pursuant to the
terms of any such  employee  benefit plan in its role as an agent or trustee for
such plan,  shall become the beneficial  owner (within the meaning of Rule 13d-3
under the  Exchange  Act) of 20%;  or (v) during  any period of two  consecutive
years,  individuals  who were  directors of the Company at the beginning of such
period shall fail to constitute a majority of the Company's  Board of Directors,
unless  the  election,   or  the   nomination  for  election  by  the  Company's
shareholders, of each new director was approved by a vote of at least two-thirds
of the directors then still in office who were directors at the beginning of the
period.
                                        4
<PAGE>
         14.  Securities  Act.  The  Company  shall have the right,  but not the
obligation, to cause the shares of Stock issuable upon exercise of the Option to
be registered under the appropriate  rules and regulations of the Securities and
Exchange Commission.  The Company shall not be required to deliver any shares of
Stock  pursuant  to the  exercise  of all or any part of the  Option  if, in the
opinion of counsel for the Company,  such issuance  would violate the Securities
Act of  1933  or any  other  applicable  federal  or  state  securities  laws or
regulations.  The Committee may require that Employee,  prior to the issuance of
any such shares  pursuant  to  exercise  of the Option,  sign and deliver to the
Company a written statement  ("Investment  Letter") stating (i) that Employee is
purchasing  the  shares  for  investment  and  not  with a view  to the  sale or
distribution  thereof; (ii) that Employee will not sell any shares received upon
exercise of the Option or any other shares of the Company that Employee may then
own or  thereafter  acquire  except  either  (a)  through a broker on a national
securities  exchange or (b) with the prior written approval of the Company;  and
(iii)  containing such other terms and conditions as counsel for the Company may
reasonably require to assure compliance with the Securities Act of 1933 or other
applicable  federal or state  securities laws and  regulations.  Such Investment
Letter  shall be in form and content  acceptable  to the  Committee  in its sole
discretion.  If shares of Stock or other  securities  issuable  pursuant  to the
exercise of the Option have not been registered under the Securities Act of 1933
or other applicable federal or state securities laws or regulations, such shares
shall bear a legend restricting the transferability  thereof,  such legend to be
substantially in the following form:

         "The shares represented by this certificate have not been registered or
         qualified under federal or state securities laws. The shares may not be
         offered  for sale,  sold,  pledged or  otherwise  disposed of unless so
         registered  or  qualified,  unless an  exemption  exists or unless such
         disposition is not subject to the federal or state securities laws, and
         the  availability  of any  exemption  or the  inapplicability  of  such
         securities  laws must be  established  by an opinion of counsel,  which
         opinion  and  counsel  shall  both be  reasonably  satisfactory  to the
         Company."

         15. Federal and State Taxes.  Upon exercise of the Option,  or any part
thereof, the Employee may incur certain liabilities for federal,  state or local
taxes and the Company may be required by law to withhold  such taxes for payment
to taxing authorities.  Upon determination by the Company of the amount of taxes
required  to be  withheld,  if any,  with  respect  to the  shares  to be issued
pursuant to the exercise of the Option, Employee shall pay all Federal state and
local tax withholding  requirements by having the Company withhold Stock (to the
extent that Stock is issued pursuant to the Award) having a Fair Market Value on
the date that tax is to be determined equal to the tax otherwise  required to be
withheld.

         16.  Administration.  This  Option  Agreement  shall  at all  times  be
administered  by the  Committee  and  decisions of the majority of the Committee
with  respect  thereto and to this Option  Agreement  shall be final and binding
upon Employee and the Company.

         17.  Obligation  to  Exercise.  Employee  shall have no  obligation  to
exercise any option granted by this Agreement.

         18.  Governing  Law. This Option  Agreement  shall be  interpreted  and
administered  under the laws of the State of Arizona  without regard to conflict
of law principles.
                                        5
<PAGE>
         19. Amendments.  This Option Agreement may be amended only by a written
agreement  executed  by the  Company and  Employee.  The  Company  and  Employee
acknowledge  that changes in federal tax laws enacted  subsequent to the Date of
Grant,  and  applicable  to stock  options,  may provide for tax benefits to the
Company or Employee. In any such event, the Company and Employee agree that this
Option  Agreement  may be amended as  necessary  to secure for the  Company  and
Employee any benefits that may result from such legislation.  Any such amendment
shall be made only upon the mutual  consent of the  parties,  which  consent (of
either party) may be withheld for any reason.

         IN WITNESS WHEREOF,  the Company has caused this Option Agreement to be
duly executed and Employee has hereunto set his or her hand as of the date first
written above.


                                                MICROTEST, INC.


                                                By
                                                  ------------------------------
                                                      Chairman of the Board and
                                                      Chief Executive Officer


                                        6

                                   EXHIBIT 4.3

                      NON-QUALIFIED STOCK OPTION AGREEMENT

         This Non-Qualified Stock Option Agreement is made as of this 9th day of
June, 1997 (which date is hereinafter referred to as the "Date of Grant") by and
among MICROTEST,  INC., a Delaware corporation  (hereinafter  referred to as the
"Company") and Charles V. Mihaylo  (hereinafter  referred to as "Employee").  If
Employee is presently or  subsequently  becomes  employed by a subsidiary of the
Company,  the term "Company" shall be deemed to refer collectively to Microtest,
Inc. and the subsidiary or subsidiaries which employ the Employee.

                                    RECITALS

         A. From time to time, the Company grants stock options to key employees
and  officers of the Company as an  incentive to  encourage  key  employees  and
officers to remain in its  employment  and to enhance the ability of the Company
to attract new employees  whose  services are considered  unusually  valuable by
providing an  opportunity  to have a proprietary  interest in the success of the
Company; and

         B. The Compensation  Committee (the "Committee") of the Company's Board
of  Directors  believes  that the  granting of the Option  herein  described  to
Employee is consistent with the stated purposes for the grant of a stock option;

         NOW, THEREFORE, in consideration of the mutual covenants and conditions
hereinafter set forth and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Company and Employee agree
as follows:

         1. Grant of Option. The Company hereby grants to Employee the right and
option  (hereinafter  referred to as the  "Option")  to purchase an aggregate of
150,000 shares (such number being subject to adjustment as provided in paragraph
number 12 hereof) of  Microtest  Common  Stock  (the  "Stock")  on the terms and
conditions  herein set forth.  This Option may be  exercised in whole or in part
and from time to time only to the extent the Option is vested and as hereinafter
provided.

         2.  Vesting.  The shares  shall vest 72 months  after the Date of Grant
unless otherwise accelarated by Board of Director approval.


         Purchase Price.  The  price at which  Employee  shall  be  entitled  to
                  purchase the Stock  covered by the Option shall be $3.8125 per
                  share (the Fair Market Value on the Date of Grant).

         4. Term of Option.  The Option  hereby  granted  shall be and remain in
force and effect for a period of ten (10) years from the Date of Grant,  through
and including the normal close of

                                        1
<PAGE>
business  of the  Company  on  June  9,  2007  (hereinafter  referred  to as the
"Expiration  Date"),  subject to earlier termination as provided in paragraphs 8
and 9 hereof.

         5.  Exercise of Option.  The Option may be exercised by Employee at any
time and from time to time on or after  twelve (12) months and one day after the
Date of Grant,  and  through  the  Expiration  Date as to all or any part of the
shares of the Stock then vested by delivery to the Company of written  notice of
exercise  and payment of the  purchase  price as provided in  paragraphs 5 and 6
hereof.

         6. Method of Exercising Option.  Subject to the terms and conditions of
this Option  Agreement,  the Option may be exercised  by timely  delivery to the
Company of written notice,  which notice shall be effective on the date received
by the  Company  (the  "Effective  Date").  The notice  shall  state  Employee's
election  to exercise  the  Option,  the number of shares in respect of which an
election to exercise has been made, the method of payment elected (see paragraph
7 hereof),  the exact name or names in which the shares will be  registered  and
the Social  Security  number of  Employee.  Such  notice  shall be signed by the
Employee  and shall be  accompanied  by  payment of the  purchase  price of such
shares.  In the event the Option shall be exercised by a person or persons other
than  Employee  pursuant to  paragraph 9 hereof,  such notice shall be signed by
such other person or persons and shall be accompanied by proof acceptable to the
Company of the legal right of such person or persons to exercise the Option. All
shares  delivered by the Company upon exercise of the Option as provided  herein
shall be fully paid and nonassessable upon delivery.

         7. Method of Payment for Options. Payment for shares purchased upon the
exercise  of the  Option  shall be made by the  Employee  in cash or such  other
method  permitted  by  the  Committee  in its  sole  discretion,  including  (i)
tendering shares, (ii) surrendering a stock award valued at Fair Market Value on
the date of surrender,  (iii) authorizing a third party to sell the shares (or a
sufficient  portion  thereof)  acquired  upon  exercise  of a stock  option  and
assigning  the  delivery  to the  Company  of a  sufficient  amount  of the sale
proceeds to pay for all the shares acquired  through such exercise,  or (iv) any
combination of the above.  For purposes of this  Agreement,  "Fair Market Value"
means with respect to Stock or any other property, the fair market value of such
Stock or other property as determined by the Committee in its discretion,  under
one of the  following  methods:  (i) the  average of the  closing  bid and asked
prices for the Stock as reported on any  national  securities  exchange on which
the Stock is then listed  (which shall include the Nasdaq  National  Market) for
that date or, if no prices are so  reported  for that date,  such  prices on the
next  preceding  date for which closing bid and asked prices were  reported;  or
(ii) the price as determined by such methods or procedures as may be established
from time to time by the Committee.

         8. Termination of Employment.  In the event that Employee is terminated
as an employee  of or  consultant  to the Company for any reason  other than for
Cause,  as defined below,  then Employee may at any time within three (3) months
next  succeeding the effective date of such  termination  exercise the Option to
the extent that  Employee  was  entitled  to exercise  the Option at the date of
termination, provided that in no event shall the Option, or any part thereof, be
exercisable  after the Expiration  Date. If Employee's  employment is terminated
for Cause, the Option shall lapse at the time of such termination.  For purposes
of this  Agreement,  "Cause" means if the Committee,  in its reasonable and good
faith discretion, determines that Employee (i) has developed or pursued

                                        2
<PAGE>
interests  substantially  adverse to the Company,  (ii) materially  breached any
employment,  engagement  or  confidentiality  agreement or  otherwise  failed to
satisfactorily  discharge  his or her  duties,  (iii)  has  not  devoted  all or
substantially  all of his or her  business  time,  effort and  attention  to the
affairs of the Company  (or such lesser  amount as has been agreed to in writing
by the Company), (iv) is convicted of a felony involving moral turpitude, or (v)
has engaged in activities or omissions that are detrimental to the well-being of
the Company.

         9. Death of  Employee.  In the event of the death of Employee  within a
period during which the Option,  or any part thereof,  could have been exercised
by Employee,  including three (3) months after the date of Employee's death (the
"Option  Period"),  the Option  shall lapse  unless it is  exercised  within the
Option  Period and in no event later than  fifteen (15) months after the date of
Employee's death by the Employee's legal representative or representatives or by
the person or persons entitled to do so under Employee's last will and testament
or if the Employee  fails to make a  testamentary  disposition of such Option or
shall die  intestate,  by the person or persons  entitled to receive such Option
under  the  applicable  laws of  descent  and  distribution.  An  Option  may be
exercised following the death of the Employee only if the Option was exercisable
by the  Employee  immediately  prior to his or her death.  In no event shall the
Option,  or any part thereof,  be  exercisable  after the  Expiration  Date. The
Committee  shall have the right to require  evidence  satisfactory  to it of the
rights of any  person or  persons  seeking to  exercise  the  Option  under this
paragraph 9 to exercise the Option.

         10.  Nontransferability.  The Option  granted by this Option  Agreement
shall be exercisable  only during the term of the Option provided in paragraph 4
hereof and,  except as provided in  paragraphs  8 and 9 above,  only by Employee
during his lifetime  and while an Employee of the Company.  No right or interest
of employee in the option may be pledged,  encumbered,  or hypothecated to or in
favor of any party  other  than the  Company,  or shall be  subject to any lien,
obligation, or liability of Employee to any other party other than the Company.

         11.  Delivery  of Shares.  No shares of Stock shall be  delivered  upon
exercise of the Option until (i) the purchase price shall have been paid in full
in the manner herein  provided;  (ii)  applicable  taxes required to be withheld
have been paid or withheld in full; (iii) approval of any governmental authority
required in connection  with the Option,  or the issuance of shares  thereunder,
has been  received  by the  Company;  and  (iv) if  required  by the  Committee,
Employee has delivered to the Committee an Investment Letter in form and content
satisfactory to the Company as provided in paragraph 14 hereof.

         12.  Adjustments.  In the event a stock  dividend is declared  upon the
Stock,  the  shares of Stock  then  subject  to the  Option  shall be  increased
proportionately  without any change in the aggregate purchase price therefor. In
the event the Stock shall be changed into or exchanged for a different number or
class  of  shares  of  Stock  or  of  another   corporation,   whether   through
reorganization,  recapitalization,  stock split-up, combination of shares, there
shall be substituted for each such share of Stock then subject to the Option the
number and class of shares of Stock into which each  outstanding  share of Stock
shall be so exchanged,  all without any change in the aggregate  purchase  price
for the shares then subject to the Option.

                                        3
<PAGE>
         13.  Change  of  Control.  A  Change  of  Control  shall,  in the  sole
discretion of the Committee:

                  (a) cause  the  Option to  become  fully  exercisable  and all
         restrictions  to lapse and allow  Employee  the right to  exercise  the
         Option prior to the occurrence of the event  otherwise  terminating the
         Option  over such  period as the  Committee,  in its sole and  absolute
         discretion, shall determine; or

                  (b) cause the Option to terminate, provided that the surviving
         or resulting  corporation shall tender an option or options to purchase
         its shares or exercise such rights on terms and  conditions,  as to the
         number of shares and rights and  otherwise,  which shall  substantially
         preserve the rights and benefits of Employee under this Agreement.

For purposes of this  Agreement,  "Change in Control" means and includes each of
the following: (i) there shall be consummated any consolidation or merger of the
Company in which the  Company is not the  continuing  or  surviving  entity,  or
pursuant to which  Stock  would be  converted  into cash,  securities,  or other
property,  other  than a merger  of the  Company  in which  the  holders  of the
Company's  Stock  immediately  prior to the merger  have the same  proportionate
ownership of beneficial  interest of common stock or other voting  securities of
the  surviving  entity  immediately  after  the  merger;  (ii)  there  shall  be
consummated any sale, lease, exchange or other transfer (in one transaction or a
series of related transactions) of assets or earning power aggregating more than
40% of the assets or earning power of the Company and its subsidiaries (taken as
a whole);  (iii) the  shareholders  of the  Company  shall  approve  any plan or
proposal for liquidation or dissolution of the Company; (iv) any person (as such
term is used in Sections  13(d) and 14(d)(2) of the Exchange Act) other than any
employee  benefit  plan of the Company or any  subsidiary  of the Company or any
entity  holding  shares of capital  stock of the  Company for or pursuant to the
terms of any such  employee  benefit plan in its role as an agent or trustee for
such plan,  shall become the beneficial  owner (within the meaning of Rule 13d-3
under the  Exchange  Act) of 20%;  or (v) during  any period of two  consecutive
years,  individuals  who were  directors of the Company at the beginning of such
period shall fail to constitute a majority of the Company's  Board of Directors,
unless  the  election,   or  the   nomination  for  election  by  the  Company's
shareholders, of each new director was approved by a vote of at least two-thirds
of the directors then still in office who were directors at the beginning of the
period.

         14.  Securities  Act.  The  Company  shall have the right,  but not the
obligation, to cause the shares of Stock issuable upon exercise of the Option to
be registered under the appropriate  rules and regulations of the Securities and
Exchange Commission.  The Company shall not be required to deliver any shares of
Stock  pursuant  to the  exercise  of all or any part of the  Option  if, in the
opinion of counsel for the Company,  such issuance  would violate the Securities
Act of  1933  or any  other  applicable  federal  or  state  securities  laws or
regulations.  The Committee may require that Employee,  prior to the issuance of
any such shares  pursuant  to  exercise  of the Option,  sign and deliver to the
Company a written statement  ("Investment  Letter") stating (i) that Employee is
purchasing  the  shares  for  investment  and  not  with a view  to the  sale or
distribution  thereof; (ii) that Employee will not sell any shares received upon
exercise of the Option or any other shares of the Company that Employee may then
own or  thereafter  acquire  except  either  (a)  through a broker on a national
securities
                                        4
<PAGE>
exchange  or (b) with the  prior  written  approval  of the  Company;  and (iii)
containing  such other  terms and  conditions  as counsel  for the  Company  may
reasonably require to assure compliance with the Securities Act of 1933 or other
applicable  federal or state  securities laws and  regulations.  Such Investment
Letter  shall be in form and content  acceptable  to the  Committee  in its sole
discretion.  If shares of Stock or other  securities  issuable  pursuant  to the
exercise of the Option have not been registered under the Securities Act of 1933
or other applicable federal or state securities laws or regulations, such shares
shall bear a legend restricting the transferability  thereof,  such legend to be
substantially in the following form:

         "The shares represented by this certificate have not been registered or
         qualified under federal or state securities laws. The shares may not be
         offered  for sale,  sold,  pledged or  otherwise  disposed of unless so
         registered  or  qualified,  unless an  exemption  exists or unless such
         disposition is not subject to the federal or state securities laws, and
         the  availability  of any  exemption  or the  inapplicability  of  such
         securities  laws must be  established  by an opinion of counsel,  which
         opinion  and  counsel  shall  both be  reasonably  satisfactory  to the
         Company."

         15. Federal and State Taxes.  Upon exercise of the Option,  or any part
thereof, the Employee may incur certain liabilities for federal,  state or local
taxes and the Company may be required by law to withhold  such taxes for payment
to taxing authorities.  Upon determination by the Company of the amount of taxes
required  to be  withheld,  if any,  with  respect  to the  shares  to be issued
pursuant to the exercise of the Option, Employee shall pay all Federal state and
local tax withholding  requirements by having the Company withhold Stock (to the
extent that Stock is issued pursuant to the Award) having a Fair Market Value on
the date that tax is to be determined equal to the tax otherwise  required to be
withheld.

         16.  Administration.  This  Option  Agreement  shall  at all  times  be
administered  by the  Committee  and  decisions of the majority of the Committee
with  respect  thereto and to this Option  Agreement  shall be final and binding
upon Employee and the Company.

         17.  Obligation  to  Exercise.  Employee  shall have no  obligation  to
exercise any option granted by this Agreement.

         18.  Governing  Law. This Option  Agreement  shall be  interpreted  and
administered  under the laws of the State of Arizona  without regard to conflict
of law principles.

         19. Amendments.  This Option Agreement may be amended only by a written
agreement  executed  by the  Company and  Employee.  The  Company  and  Employee
acknowledge  that changes in federal tax laws enacted  subsequent to the Date of
Grant,  and  applicable  to stock  options,  may provide for tax benefits to the
Company or Employee. In any such event, the Company and Employee agree that this
Option  Agreement  may be amended as  necessary  to secure for the  Company  and
Employee any benefits that may result from such legislation.  Any such amendment
shall be made only upon the mutual  consent of the  parties,  which  consent (of
either party) may be withheld for any reason.

                                        5
<PAGE>
         IN WITNESS WHEREOF,  the Company has caused this Option Agreement to be
duly executed and Employee has hereunto set his or her hand as of the date first
written above.


                                              MICROTEST, INC.


                                              By
                                                --------------------------------
                                                    Chairman of the Board and
                                                    Chief Executive Officer



                                        6

                                    EXHIBIT 5

                                December 4, 1998

MICROTEST, INC.
4747 North 22nd Street
Phoenix, AZ 85016

            Re:   Non-Qualified  Stock  Option  Agreements  between  Charles  V.
                  Mihaylo and Microtest, Inc. (the "Company")

Ladies and Gentlemen:

         We have  acted  as  counsel  to the  Company  in  connection  with  its
Registration Statement on Form S-8 (the "Registration Statement"),  filed by the
Company with the Securities and Exchange  Commission under the Securities Act of
1933, as amended, relating to the registration of 60,000 shares of the Company's
Common  Stock,  $.001 par value  (the  "Shares")  issuable  pursuant  to options
granted in connection  with the  above-referenced  agreement.  It is our opinion
that:

         1.       The Company has been duly organized and is validly existing as
                  a corporation under the laws of the State of Delaware.

         2.       The Shares,  when issued and sold in accordance with the terms
                  of the  agreement,  will be validly  issued,  fully paid,  and
                  non-assessable.

         In  rendering  this  opinion,  we have  reviewed  and relied  upon such
documents  and  records of the  Company  as we have  deemed  necessary  and have
assumed the following:

                  (i) the genuineness of all signatures and the  authenticity of
documents  submitted to us as originals,  and the conformity to originals of all
documents submitted to us as copies;

                  (ii)  the  accuracy,  completeness,  and  genuineness  of  all
representations and certifications  with respect to factual matters,  made to us
by officers of the Company and public officials; and

                  (iii) the accuracy and completeness of Company records.

         The  opinions  expressed  herein are limited  solely to the laws of the
State of Delaware.  We express no opinion on the laws of any other  jurisdiction
or the applicability or effect of any such laws or principles.

         The opinions  expressed herein are based upon the law and other matters
in  effect  on the date  hereof,  and we  assume  no  obligation  to  revise  or
supplement this opinion should such law be
<PAGE>
changed by legislative action,  judicial decision,  or otherwise,  or should any
facts or other matters upon which we have relied be changed.

         We hereby  consent  to the use of this  opinion  as an  exhibit  to the
Registration Statement.

                                Very truly yours,

                                SNELL & WILMER L.L.P.




                                        2

                                  EXHIBIT 23.1

INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in this  Registration  Statement of
Microtest Inc. on Form S-8, of our report dated  February 4, 1998,  appearing in
the Annual Report on Form 10-K of Microtest Inc. for the year ended December 31,
1997.




DELOITTE & TOUCHE LLP
Phoenix, Arizona
December 4, 1998


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission